Royalty Pharma plc announced on May 16, 2025, the successful closing of the acquisition of its external manager, RP Management, LLC. This transaction received overwhelming support from Royalty Pharma’s shareholders, with 99.9% of votes cast in favor.
The completion of this internalization marks a significant new chapter for Royalty Pharma, as it transitions from an externally managed model to an integrated company. All employees of the former Manager have now become direct employees of Royalty Pharma.
This transformative step is expected to enhance long-term shareholder value through a simplified corporate structure, strengthened shareholder alignment, enhanced governance, significant cash savings, and increased economic return on investments. The company plans to update its full-year 2025 guidance to reflect the impact of this internalization when it reports its second quarter 2025 financial results.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.